You are viewing the site in preview mode
Skip to main content
|
Outcome
|
Study design
|
Number of Trials
|
Sample size
|
SMD/RR/OR/HR
|
95% CI
|
P
|
I2
|
|---|
|
ANC
|
RCTs
|
4
|
130
|
SMD, − 1.20
|
− 2.32, − 0.08
|
0.04*
|
86%#
|
|
nRCTs
|
10
|
341
|
SMD, − 0.54
|
− 1.05, − 0.03
|
0.04*
|
74%#
|
|
PLT
|
RCTs
|
4
|
157
|
SMD, − 0.60
|
− 1.17, − 0.02
|
0.04*
|
63%#
|
|
nRCTs
|
10
|
381
|
SMD, − 0.70
|
− 1.24, − 0.16
|
0.01*
|
79%#
|
|
aGVHD
|
RCTs
|
3
|
98
|
RR, 0.84
|
0.59, 1.19
|
0.33
|
0%
|
|
nRCTs
|
9
|
377
|
RR, 0.74
|
0.60, 0.91
|
0.005*
|
0%
|
|
cGVHD
|
RCTs
|
4
|
156
|
RR, 0.53
|
0.33, 0.87
|
0.01*
|
25%
|
|
nRCTs
|
10
|
380
|
RR, 0.50
|
0.33, 0.75
|
0.001*
|
0%
|
|
OS
|
RCTs
|
4
|
164
|
HR, 1.54
|
0.81, 2.93
|
0.18
|
0%
|
|
nRCTs
|
6
|
231
|
HR, 0.60
|
0.35, 1.02
|
0.06
|
34%
|
|
RR
|
RCTs
|
5
|
186
|
RR, 1.34
|
0.74, 2.43
|
0.34
|
13%
|
|
nRCTs
|
4
|
184
|
RR, 0.74
|
0.45, 1.22
|
0.24
|
0%
|
|
NRM
|
RCTs
|
3
|
100
|
OR, 0.59
|
0.20, 1.73
|
0.34
|
0%
|
|
nRCTs
|
3
|
97
|
OR, 0.18
|
0.06, 0.54
|
0.002*
|
0%
|
- *The difference was statistical significance
- #Significant heterogeneity needed to conduct subgroup analysis
